Efficacy and delivery strategies of the dual Rac/Cdc42 inhibitor MBQ-167 in HER2 overexpressing breast cancer

Luis Velazquez‐Vega(University of Puerto Rico, Medical Sciences Campus), Suranganie Dharmawardhane(University of Puerto Rico, Medical Sciences Campus)
Translational Oncology
March 15, 2024
Cited by 5


Related Papers